Zhejiang DiAn Diagnostics Co (300244) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang DiAn Diagnostics Co (300244) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥594.17 Million ≈ $86.95 Million USD) by net assets (CN¥8.67 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang DiAn Diagnostics Co - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Zhejiang DiAn Diagnostics Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300244 total debt and obligations for a breakdown of total debt and financial obligations.
Zhejiang DiAn Diagnostics Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang DiAn Diagnostics Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
-0.091x |
|
Xinjiang Joinworld Co Ltd
SHG:600888
|
0.014x |
|
Veris Residential Inc
NYSE:VRE
|
0.011x |
|
Vcanbio Cell & Gene Engineering Corp Ltd
SHG:600645
|
0.028x |
|
JetBlue Airways Corp
NASDAQ:JBLU
|
-0.063x |
|
Avi Ltd
JSE:AVI
|
0.245x |
|
Hyundai Doosan Infracore Co Ltd
KO:042670
|
0.072x |
|
Indo Tambangraya Megah Tbk
JK:ITMG
|
0.123x |
Annual Cash Flow Conversion Efficiency for Zhejiang DiAn Diagnostics Co (2008–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang DiAn Diagnostics Co from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang DiAn Diagnostics Co (300244) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.77 Billion ≈ $1.28 Billion |
CN¥1.21 Billion ≈ $176.68 Million |
0.138x | -29.01% |
| 2023-12-31 | CN¥9.90 Billion ≈ $1.45 Billion |
CN¥1.92 Billion ≈ $281.15 Million |
0.194x | +12.44% |
| 2022-12-31 | CN¥9.50 Billion ≈ $1.39 Billion |
CN¥1.64 Billion ≈ $239.89 Million |
0.173x | -2.13% |
| 2021-12-31 | CN¥7.48 Billion ≈ $1.09 Billion |
CN¥1.32 Billion ≈ $192.85 Million |
0.176x | -31.31% |
| 2020-12-31 | CN¥6.03 Billion ≈ $882.20 Million |
CN¥1.55 Billion ≈ $226.41 Million |
0.257x | +172.91% |
| 2019-12-31 | CN¥5.14 Billion ≈ $751.88 Million |
CN¥483.19 Million ≈ $70.71 Million |
0.094x | +18.49% |
| 2018-12-31 | CN¥4.70 Billion ≈ $688.18 Million |
CN¥373.24 Million ≈ $54.62 Million |
0.079x | +507.28% |
| 2017-12-31 | CN¥2.95 Billion ≈ $431.21 Million |
CN¥38.51 Million ≈ $5.64 Million |
0.013x | -74.84% |
| 2016-12-31 | CN¥2.55 Billion ≈ $372.55 Million |
CN¥132.25 Million ≈ $19.35 Million |
0.052x | -58.11% |
| 2015-12-31 | CN¥1.06 Billion ≈ $154.94 Million |
CN¥131.29 Million ≈ $19.21 Million |
0.124x | -26.22% |
| 2014-12-31 | CN¥701.84 Million ≈ $102.70 Million |
CN¥117.95 Million ≈ $17.26 Million |
0.168x | +31.39% |
| 2013-12-31 | CN¥589.81 Million ≈ $86.31 Million |
CN¥75.44 Million ≈ $11.04 Million |
0.128x | +162.88% |
| 2012-12-31 | CN¥527.32 Million ≈ $77.16 Million |
CN¥25.66 Million ≈ $3.75 Million |
0.049x | +14.88% |
| 2011-12-31 | CN¥477.04 Million ≈ $69.81 Million |
CN¥20.20 Million ≈ $2.96 Million |
0.042x | -83.57% |
| 2010-12-31 | CN¥159.92 Million ≈ $23.40 Million |
CN¥41.23 Million ≈ $6.03 Million |
0.258x | +601.12% |
| 2009-12-31 | CN¥110.32 Million ≈ $16.14 Million |
CN¥4.06 Million ≈ $593.57K |
0.037x | +127.90% |
| 2008-12-31 | CN¥27.86 Million ≈ $4.08 Million |
CN¥-3.67 Million ≈ $-537.24K |
-0.132x | -- |
About Zhejiang DiAn Diagnostics Co
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more